Dr. Mitchell Benson, MD

NPI: 1518060425
Total Payments
$9,955
2024 Payments
$165.22
Companies
19
Transactions
80
Medicare Patients
4,936
Medicare Billing
$509,162

Payment Breakdown by Category

Other$4,000 (40.2%)
Consulting$3,740 (37.6%)
Food & Beverage$1,711 (17.2%)
Education$293.80 (3.0%)
Travel$209.71 (2.1%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $4,000 1 40.2%
Consulting Fee $3,740 3 37.6%
Food and Beverage $1,711 66 17.2%
Education $293.80 6 3.0%
Travel and Lodging $209.71 4 2.1%

Top Paying Companies

Company Total Records Latest Year
Janssen Scientific Affairs, LLC $8,025 9 $0 (2019)
Astellas Pharma US Inc $418.40 15 $0 (2024)
SANOFI-AVENTIS U.S. LLC $279.45 3 $0 (2017)
Janssen Biotech, Inc. $255.51 22 $0 (2019)
Blue Earth Diagnostics Limited $172.34 3 $0 (2023)
Bayer HealthCare Pharmaceuticals Inc. $110.33 6 $0 (2018)
COMSORT, Inc $100.00 1 $0 (2019)
Janssen Products, LP $99.00 1 $0 (2018)
BOSTON SCIENTIFIC CORPORATION $98.61 2 $0 (2017)
ABBVIE INC. $96.88 4 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $165.22 6 ABBVIE INC. ($79.21)
2023 $104.62 4 Astellas Pharma US Inc ($57.91)
2019 $2,436 11 Janssen Scientific Affairs, LLC ($2,229)
2018 $2,459 34 Janssen Scientific Affairs, LLC ($1,743)
2017 $4,790 25 Janssen Scientific Affairs, LLC ($4,053)

All Payment Transactions

80 individual payment records from CMS Open Payments — Page 1 of 4

Date Company Product Nature Form Amount Type
08/23/2024 ABBVIE INC. BOTOX (Biological) Food and Beverage In-kind items and services $27.67 General
Category: BOTOX THERAPEUTIC
08/20/2024 ABBVIE INC. BOTOX (Biological) Food and Beverage In-kind items and services $30.62 General
Category: BOTOX THERAPEUTIC
04/02/2024 Merck Sharp & Dohme LLC KEYTRUDA (Biological) Food and Beverage In-kind items and services $29.12 General
Category: ONCOLOGY
03/04/2024 ABBVIE INC. BOTOX (Biological) Food and Beverage In-kind items and services $20.92 General
Category: BOTOX THERAPEUTIC
02/22/2024 Astellas Pharma US Inc Myrbetriq (Drug) Food and Beverage In-kind items and services $27.01 General
Category: Urology
01/18/2024 Astellas Pharma US Inc Myrbetriq (Drug) Food and Beverage In-kind items and services $29.88 General
Category: Urology
12/09/2023 AbbVie Inc. BOTOX (Biological) Food and Beverage In-kind items and services $17.67 General
Category: BOTOX THERAPEUTIC
12/07/2023 Blue Earth Diagnostics Limited POSLUMA (Drug) Food and Beverage In-kind items and services $29.04 General
Category: Diagnostic Imaging
06/30/2023 Astellas Pharma US Inc Xtandi (Drug) Food and Beverage In-kind items and services $32.93 General
Category: Oncology
02/25/2023 Astellas Pharma US Inc Myrbetriq (Drug) Food and Beverage In-kind items and services $24.98 General
Category: Urology
10/12/2019 OPKO Pharmaceuticals, LLC Rayaldee (Drug) Food and Beverage In-kind items and services $13.47 General
Category: Hyperparathyroidism
10/11/2019 COMSORT, Inc KEYTRUDA (Biological) Consulting Fee Cash or cash equivalent $100.00 General
Category: ONCOLOGY
05/30/2019 Janssen Biotech, Inc. Erleada (Drug), ZYTIGA Food and Beverage In-kind items and services $14.46 General
Category: Oncology
05/01/2019 Janssen Biotech, Inc. Erleada (Drug), ZYTIGA Food and Beverage In-kind items and services $6.68 General
Category: Oncology
03/27/2019 Janssen Scientific Affairs, LLC Erleada (Drug) Consulting Fee Cash or cash equivalent $2,060.00 General
Category: Oncology
03/27/2019 Janssen Scientific Affairs, LLC Erleada (Drug) Food and Beverage In-kind items and services $125.00 General
Category: Oncology
03/27/2019 Janssen Scientific Affairs, LLC Erleada (Drug) Travel and Lodging Cash or cash equivalent $43.82 General
Category: Oncology
03/26/2019 Janssen Biotech, Inc. Erleada (Drug), ZYTIGA Food and Beverage In-kind items and services $5.32 General
Category: Oncology
02/28/2019 Janssen Pharmaceuticals, Inc Erleada (Drug) Education In-kind items and services $11.60 General
Category: Oncology
01/31/2019 Coloplast Corp SPEEDICATH (Device) Food and Beverage Cash or cash equivalent $22.09 General
Category: CONTINENCE
01/10/2019 Janssen Biotech, Inc. Erleada (Drug), ZYTIGA Food and Beverage In-kind items and services $33.22 General
Category: Oncology
12/12/2018 Blue Earth Diagnostics Limited Axumin (Drug) Food and Beverage In-kind items and services $111.30 General
Category: Diagnostic Imaging
11/07/2018 Janssen Biotech, Inc. Erleada (Drug), ZYTIGA Food and Beverage In-kind items and services $7.94 General
Category: Oncology
11/01/2018 Astellas Pharma US Inc Education In-kind items and services $99.99 General
11/01/2018 Astellas Pharma US Inc Education In-kind items and services $59.99 General

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 16 1,362 2,079 $567,537 $140,201
2022 13 1,176 1,736 $451,096 $116,095
2021 15 1,268 1,893 $531,186 $134,362
2020 20 1,130 1,640 $513,279 $118,504
Total Patients
4,936
Total Services
7,348
Medicare Billing
$509,162
Procedure Codes
64

All Medicare Procedures & Services

64 procedure records from CMS Medicare Utilization — Page 1 of 3

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 274 438 $180,018 $47,511 26.4%
52000 Diagnostic exam of bladder and urethra using an endoscope Office 2023 74 105 $84,840 $23,661 27.9%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2023 55 81 $45,117 $12,848 28.5%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 144 171 $47,367 $12,352 26.1%
J9217 Leuprolide acetate (for depot suspension), 7.5 mg Office 2023 14 84 $46,452 $11,389 24.5%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 43 43 $27,305 $6,440 23.6%
99205 New patient office or other outpatient visit, 60-74 minutes Office 2023 32 32 $25,504 $6,240 24.5%
36415 Insertion of needle into vein for collection of blood sample Office 2023 401 655 $8,425 $5,461 64.8%
55706 Needle biopsy of prostate gland using image guidance Facility 2023 13 13 $19,136 $4,033 21.1%
51798 Ultrasound measurement of bladder capacity after voiding Office 2023 223 347 $26,719 $3,395 12.7%
52005 Insertion of tube into ureter using an endoscope through bladder area Facility 2023 11 14 $14,658 $1,582 10.8%
55700 Biopsy of prostate gland Facility 2023 12 12 $10,296 $1,487 14.4%
52204 Biopsy of bladder using an endoscope Facility 2023 12 12 $17,508 $1,270 7.3%
96402 Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle Office 2023 17 32 $4,064 $1,005 24.7%
45990 Diagnostic exam of anus and rectum under anesthesia Facility 2023 14 16 $7,152 $830.24 11.6%
76872 Ultrasound scan of pelvic region through rectum Facility 2023 23 24 $2,976 $695.52 23.4%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 184 305 $125,355 $31,919 25.5%
52000 Diagnostic exam of bladder and urethra using an endoscope Office 2022 66 98 $79,184 $22,561 28.5%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 198 245 $67,865 $18,292 27.0%
52224 Destruction of growth of bladder and urethra using an endoscope, less than 0.5 cm Office 2022 11 11 $30,019 $8,870 29.5%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2022 40 50 $27,850 $8,315 29.9%
55706 Needle biopsy of prostate gland using image guidance Facility 2022 22 22 $32,384 $8,066 24.9%
99205 New patient office or other outpatient visit, 60-74 minutes Office 2022 30 30 $23,910 $6,058 25.3%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 35 35 $22,225 $5,234 23.6%
51798 Ultrasound measurement of bladder capacity after voiding Office 2022 189 306 $23,562 $3,008 12.8%

About Dr. Mitchell Benson, MD

Dr. Mitchell Benson, MD is a Urology healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1518060425.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mitchell Benson, MD has received a total of $9,955 in payments from pharmaceutical and medical device companies, with $165.22 received in 2024. These payments were reported across 80 transactions from 19 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($4,000).

As a Medicare-enrolled provider, Benson has provided services to 4,936 Medicare beneficiaries, totaling 7,348 services with total Medicare billing of $509,162. Data is available for 4 years (2020–2023), covering 64 distinct procedure/service records.

Practice Information

  • Specialty Urology
  • Location New York, NY
  • Active Since 09/06/2006
  • Last Updated 06/17/2024
  • Taxonomy Code 208800000X
  • Entity Type Individual
  • NPI Number 1518060425

Products in Payments

  • Erleada (Drug) $4,126
  • DARZALEX (Biological) $4,000
  • NO PRODUCT DISCUSSED (Drug) $279.45
  • ZYTIGA (Drug) $220.65
  • Axumin (Drug) $143.30
  • XTANDI (Drug) $129.67
  • KEYTRUDA (Biological) $129.12
  • Myrbetriq (Drug) $117.41
  • Xofigo (Drug) $110.33
  • GREENLIGHT (Device) $98.61
  • BOTOX (Biological) $96.88
  • Rayaldee (Drug) $80.74
  • Xtandi (Drug) $79.57
  • ARN-509 (Biological) $52.97
  • ELIGARD (Drug) $37.67
  • POSLUMA (Drug) $29.04
  • SPEEDICATH (Device) $22.09
  • PROVENGE (Drug) $21.95
  • Valleylab FT10 (Device) $19.76

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Urology Doctors in New York